Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pimurutamab
Neoplasm
Shanghai Henlius Biotech
P1
CC
(43)
Pirtobrutinib
Burkitt Lymphoma
Medical College of Wisconsin
P1
CC
(43)
Pirtobrutinib
Plasma Cell Myeloma
Eli Lilly and Company
P1
CC
(43)
pit565
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
P1
CC
(43)
pit565
B-Cell Non-Hodgkin Lymphoma
Novartis Pharmaceuticals
P1
CC
(43)
Pittsburgh Compound B Unlabelled
Traumatic Brain Injury
University of North Carolina, Chapel Hill
P1
CC
(43)
Pittsburgh Compound B Unlabelled
Ovarian Cancer
University of Alabama at Birmingham
P1
CC
(43)
Pittsburgh Compound B Unlabelled
Spinal Cord Injury
Yale University
P1
CC
(43)
Pittsburgh Compound B Unlabelled
Radiculopathy
Yale University
P1
CC
(43)
PL54
Phenylketonuria
Chongqing Peg-Bio Biopharm Co., Ltd.
P1
CC
(43)
Plerixafor
Acute Leukemia
Stanford University
P1
CC
(43)
Plerixafor
Hematopoietic And Lymphoid System Neoplasm
Stanford University
P1
CC
(43)
Plerixafor
Myeloproliferative Neoplasm
Stanford University
P1
CC
(43)
Plosaracetam
Major Depressive Disorder
Syndesi Therapeutics
P1
CC
(43)
Plx-61639
Gastric Squamous Cell Carcinoma
Plexium, Inc.
P1
CC
(43)
Plx-61639
Gastroesophageal Junction Adenocarcinoma
Plexium, Inc.
P1
CC
(43)
Plx-61639
Non-Small Cell Lung Carcinoma
Plexium, Inc.
P1
CC
(43)
pm534
Cancer
PharmaMar
P1
CC
(43)
Pmcc-Coe-Kma
Plasma Cell Myeloma
Peter MacCallum Cancer Centre, Australia
P1
CC
(43)
P-Muc1C-Allo1 Car-T Cells
Nasopharyngeal Carcinoma
Poseida Therapeutics, Inc.
P1
CC
(43)
Polatuzumab Vedotin
ALK-Positive Large B-Cell Lymphoma
University of Washington
P1
CC
(43)
Polatuzumab Vedotin
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MD
P1
CC
(43)
Polatuzumab Vedotin
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P1
CC
(43)
Polatuzumab Vedotin
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
University of Washington
P1
CC
(43)
Polyphenol Whole Tumor Cell Vaccine
Cancer
Xingchen Peng
P1
CC
(43)
Showing 3901 to 3925 of 9,920 assets
Previous
Page 157 of 397
Next
